1. Continuing clozapine treatment despite neutropenia

   • David Esposito
   • Frédéric Rouillon
   • Frédéric Limosin

   Review Article 30 November 2004 Pages: 759 - 764

2. Pharmacoepidemiology and the “Impact Factor”

   • Emilio J. Sanz

   Special Article 03 December 2004 Pages: 765 - 772

3. Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis

   • K. Skrętkowicz
   • J. Skrętkowicz
   • A. Sysa-Jędrzejowska

   Pharmacogenetics 24 November 2004 Pages: 773 - 778

   

4. A pharmacokinetic study comparing single and repeated oral doses of 20 mg and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects

   • M. Hassan-Alin
   • T. Andersson
   • K. Röhss

   Pharmacokinetics and Disposition 01 December 2004 Pages: 779 - 784

   

5. Effect of menthol on the pharmacokinetics and pharmacodynamics of felodipine in healthy subjects

   • Ayse Gelal
   • Dilara Balkan
   • Neal L. Benowitz

   Pharmacokinetics and Disposition 11 December 2004 Pages: 785 - 790

   

6. Effect of erythromycin on metabolism of quetiapine in Chinese suffering from schizophrenia

   • Kun-Yan Li
   • Xin Li
   • Huan-De Li

   Pharmacokinetics and Disposition 14 December 2004 Pages: 791 - 795

   

7. Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular diseases from Germany

   • Sebastian Harder
   • Philipp Fischer
   • Horst Baas

   Pharmacoepidemiology and Prescription 01 December 2004 Pages: 797 - 805

   

8. Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?

   • Meret Martin-Facklam
   • Jens Rengelshausen
   • Walter E. Haefeli

   Pharmacoepidemiology and Prescription 14 December 2004 Pages: 807 - 811

   

9. Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study

   • Nathalie Lechevallier-Michel
   • Marion Gautier-Bertrand
   • On behalf of the 3C Study group

   Pharmacoepidemiology and Prescription 14 December 2004 Pages: 813 - 819

10. Agranulocytosis associated with dipyrone (metamizol)

    • Luisa Ibáñez
    • Xavier Vidal
    • Joan-Ramon Laporte

    Pharmacoepidemiology and Prescription 03 December 2004 Pages: 821 - 829

    

11. Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004)

    • JL Hoven
    • FM Haaijer-Ruskamp
    • R.H. Vander Stichele

    Conference Report 09 December 2004 Pages: 831 - 834

12. Levetiracetam in the treatment of vascular chorea: a case report

    • Marco D’Amelio
    • Graziella Callari
    • Giovanni Savettieri

    Letter to the Editors 03 December 2004 Pages: 835 - 836